Serving hundreds of leading biopharmaceutical companies globally:

Generated: January 21, 2019

DrugPatentWatch Database Preview

Torrent Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for TORRENT PHARMS, and what generic and branded alternatives to TORRENT PHARMS drugs are available?

TORRENT PHARMS has sixty-nine approved drugs.

There is one tentative approval on TORRENT PHARMS drugs.

Summary for Torrent Pharms

US Patents:	0
Tradenames:	60
Ingredients:	59
NDAs:	69

Drugs and US Patents for Torrent Pharms

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Torrent Pharms Ltd	LEVETIRACETAM	levetiracetam	TABLET, EXTENDED RELEASE;ORAL	091338-002	May 29, 2012	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Torrent Pharms Ltd	AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE	amlodipine besylate; hydrochlorothiazide; valsartan	TABLET;ORAL	201593-004	Jun 3, 2015	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Torrent Pharms	DONEPEZIL HYDROCHLORIDE	donepezil hydrochloride	TABLET;ORAL	090686-002	May 31, 2011	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Torrent Pharms Ltd	OLANZAPINE	olanzapine	TABLET;ORAL	091434-001	Apr 23, 2012	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Torrent Pharms Ltd	CELECOXIB	celecoxib	CAPSULE;ORAL	207677-002	Dec 23, 2015	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Torrent Pharms Ltd	LAMOTRIGINE	lamotrigine	TABLET, EXTENDED RELEASE;ORAL	203370-002	Dec 23, 2013	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Torrent Pharms Ltd	ANAGRELIDE HYDROCHLORIDE	anagrelide hydrochloride	CAPSULE;ORAL	209151-001	Jun 30, 2017	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla

US Army

Boehringer Ingelheim

Covington

Harvard Business School

Chubb

Daiichi Sankyo

Fuji

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.